---
layout: post
title: "Prescription Drug User Fee Rates for Fiscal Year 2026"
date: 2026-02-04 21:48:57 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-14413
original_published: 2025-07-30 00:00:00 +0000
significance: 8.00
---

# Prescription Drug User Fee Rates for Fiscal Year 2026

**Published:** February 04, 2026 21:48 UTC
**Source:** Federal Register
**Original Published:** July 30, 2025 00:00 UTC
**Document Number:** 2025-14413

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing the rates for prescription drug user fees for fiscal year (FY) 2026. The Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended by the Prescription Drug User Fee Amendments of 2022 (PDUFA VII), authorizes FDA to collect application fees for certain applications for the review of human drug and biological products and prescription drug program fees for certain approved products. This notice establishes the fee rates for FY 2026.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/07/30/2025-14413/prescription-drug-user-fee-rates-for-fiscal-year-2026)
- API: https://www.federalregister.gov/api/v1/documents/2025-14413

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
